Literature DB >> 17018730

Cytotoxic chemotherapy for advanced or recurrent cervical cancer.

J A Green1, G Lainakis.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17018730     DOI: 10.1093/annonc/mdl265

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Buformin increases radiosensitivity in cervical cancer cells via cell-cycle arrest and delayed DNA-damage repair.

Authors:  Ling Chen; Ting Zhang; Qiuli Liu; Mei Tang; Yu'e Yang; Yuan Wang; Haifeng Qiu; Jinjin Yu
Journal:  Exp Biol Med (Maywood)       Date:  2018-10

2.  The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.

Authors:  Cathy Eng; George J Chang; Y Nancy You; Prajnan Das; Miguel Rodriguez-Bigas; Yan Xing; Jean-Nicolas Vauthey; Jane E Rogers; Aki Ohinata; Priyanka Pathak; Salil Sethi; Jonathan K Phillips; Christopher H Crane; Robert A Wolff
Journal:  Oncotarget       Date:  2014-11-30

3.  The effect of Ganoderma lucidum extract on immunological function and identify its anti-tumor immunostimulatory activity based on the biological network.

Authors:  Ruolin Zhao; Qilong Chen; Yu-Min He
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

4.  Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression.

Authors:  Junye Liu; Le Yang; Jian Zhang; Jing Zhang; Yongbin Chen; Kangchu Li; Yurong Li; Yan Li; Libo Yao; Guozhen Guo
Journal:  BMC Cancer       Date:  2012-08-27       Impact factor: 4.430

5.  Antitumor and antimetastatic activities of chloroform extract of medicinal mushroom Cordyceps taii in mouse models.

Authors:  Ru-Ming Liu; Xiao-Jie Zhang; Gui-You Liang; Yong-Fu Yang; Jian-Jiang Zhong; Jian-Hui Xiao
Journal:  BMC Complement Altern Med       Date:  2015-07-09       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.